Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting.
Saved in:
| Title: | Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting. |
|---|---|
| Authors: | Rosar, Florian1 (AUTHOR), Khreish, Fadi1,2 (AUTHOR), Burgard, Caroline1 (AUTHOR), Fursov, Artyom1 (AUTHOR), Blickle, Arne1 (AUTHOR), Bartholomä, Mark1 (AUTHOR), Maus, Stephan1 (AUTHOR), Bastian, Moritz B.1 (AUTHOR), Speicher, Tilman1 (AUTHOR), Schaefer-Schuler, Andrea1 (AUTHOR), Ezziddin, Samer1,3 (AUTHOR) samer.ezziddin@uks.eu |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Apr2026, Vol. 53 Issue 5, p3034-3041. 8p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
